BSE
Your Result on : Detailed News
Back
Stock Alert: Aurobindo Pharma, Likhitha Infra, Vikran Engineering, Ashoka Buildcon, Bajaj Healthcare
29-Jun-26   08:09 Hrs IST

Aurobindo Pharma announced that the United States Food and Drug Administration (USFDA) had completed an inspection at its wholly owned subsidiary, Auroactive Pharma, located in Andhra Pradesh.

Likhitha Infrastructure announced that it has received an order worth approximately Rs 510 crore ($5,40,00,000) from China Petroleum Engineering and Construction Corporation-Abu Dhabi.

Vikran Engineering said that it has accepted a turnkey EPC work order worth Rs 3,517.98 crore from NOPL Solar Projects for the development of a 969 MW AC solar power project across multiple locations in Maharashtra.

Ashoka Buildcon announced that it has received a letter of acceptance (LoA) for a four-lane highway construction project in Guyana.

Info Edge (India) announced that its board has approved the appointment of Himanshu Agarwal as chief financial officer (CFO) for a term of 5 years, effective from 17 September 2026.

Bajaj Healthcare announced that Subject Expert Committee (SEC) of Central Drugs Standard Control Organisation (CDSCO) has recommended for grant of approval for manufacturing and marketing of Cenobamate Tablets.

Powered by Capital Market - Live News

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)